Biosimilars Research Report 2018: Patent Cliffs and Regulatory Changes Driving the Growth, Competitive Scenario and Market Dynamics - ResearchAndMarkets.com

DUBLIN--()--The "Biosimilars: Patent Cliffs and Regulatory Changes Driving the Growth, Competitive Scenario and Market Dynamics" report has been added to ResearchAndMarkets.com's offering.

Biosimilars are in the limelight with various leaders in the biopharmaceutical industry eyeing these biosimilars, be it biologic innovators, generic manufacturers or contract channel partners.

The emergence of biosimilar medicines across Europe and in the United States brings the promise of new valuable sources. The forecast of more affordable options that are safe and effective opens opportunities for health systems to broaden accessibility to biologics for more patients, make resources available for investment in new domains, and bring down healthcare budgets.

With better defined regulatory pathways and expiries, Biosimilars Market will be boosted and will return a stupendous CAGR of more than 55% over the forecast period.

This report highlights the benefits and opportunities of Biosimilars in the biopharmaceutical industry, in comparison to biologics and bio betters.

The report also mentions the development strategy of Biosimilars, the regulatory framework, and approvals required for development as well as the strategies to globally commercialize biosimilars for healthcare benefits.

The information regarding biosimilars pipeline available as of now along with the upcoming clinical trials of other drugs, expiration status of major biosimilars and the emerging players to look out for is also available in this report.

Market Overview of Biosimilars market has been highlighted w.r.t. to various factors that determine the market, market segmentation by region, product, disease indication, etc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Biosimilars- Overview

4. Commercial & Technical Analysis-Biosimilars

5. Biosimilars: Market Overview

6. Biosimilars - Market Determinants

7. Biosimilars - Opportunity Vs. Restraints

8. Biosimilars Strategic Analysis SWOT & PEST

9. List of Tables

10. List of Figures

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/q9vzzr/biosimilars?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biosimilars and Biosuperiors

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biosimilars and Biosuperiors